Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03441100
Title TCR-engineered T Cells in NSCLC and HCC Patients
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immatics US, Inc.
Indications

hepatocellular carcinoma

lung squamous cell carcinoma

Therapies

Cyclophosphamide + Fludarabine

Aldesleukin

IMA202

Age Groups: adult | senior
Covered Countries USA | DEU


No variant requirements are available.